PHYSIOGENIX, INC.

Company Information
Address PHYSIOGENIX, INC.
10437 INNOVATION DR, STE 325
WAUWATOSA, WI, 53226-4838


Information

DUNS: 140323531

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Efficacy of GABAA a5 receptor inverse agonists in learning impaired rats

    Amount: $343,796.00

    DESCRIPTION (provided by applicant): The number of patients in the United States afflicted with learning and memory disorders is rapidly increasing. This necessitates the development of new, better a ...

    SBIRPhase I2010Department of Health and Human Services
  2. Consomic rat panels for pharmacogenomic studies and target identification

    Amount: $783,422.00

    Not avaiable.

    SBIRPhase II2007Department of Health and Human Services
  3. Consomic rat panels for pharmacogenomic studies and target identification

    Amount: $1,644,230.00

    DESCRIPTION (provided by applicant): PhysioGenix plans to commercialize a rat discovery platform that markedly accelerates the deployment of genetic tools for drug development by Pharma. While genetic ...

    SBIRPhase I2006Department of Health and Human Services
  4. Molecular fingerprints of alcohol-induced organ damage using new genetic models

    Amount: $251,239.00

    DESCRIPTION (provided by applicant): This SBIR project combines the use of genetic models with genomic, proteomic and metabolomic technologies as a solution to discover molecular fingerprints as bioma ...

    SBIRPhase I2006Department of Health and Human Services
  5. Combinatorial rat panels for pharmacogenetic effects

    Amount: $134,425.00

    DESCRIPTION (provided by applicant): The concept of a pre-clinical, drug screen for genetic effects was developed by PhysioGenix in Phase I of this project. The screen consists of inbred rats bred in ...

    SBIRPhase II2004Department of Health and Human Services
  6. Identifying drug toxicity signatures using QCarrays

    Amount: $498,610.00

    DESCRIPTION (provided by applicant): This Phase I SBIR project uses a new Quality Control microarray (QCarray) technology to generate Drug Toxicity Signatures (DTSs) for predicting liver toxicity ...

    SBIRPhase I2004Department of Health and Human Services
  7. Combinatorial rat panels that genetically screen anthrax

    Amount: $312,536.00

    DESCRIPTION (provided by applicant): The recent anthrax-related events have revealed the need to fill gaps in the knowledge base that compromise our response to a bioterrorist attack using Category A ...

    SBIRPhase I2003Department of Health and Human Services
  8. DESIGNER RAT MODELS THAT MIMIC TYPE 2 DIABETES

    Amount: $489,659.00

    This SBIR Phase I project will employ a new bioinformatic tool to combine in silico gene mapping and comparative genomics for predicting designer rat strains that mimic human disease. The genome sequ ...

    SBIRPhase I2002Department of Health and Human Services
  9. COMBINATORIAL RAT PANELS FOR PHARMACOGENETIC EFFECTS

    Amount: $100,000.00

    This SBIR Phase I project will create and validate a combinatorial panel of rats designed to detect genetic differences to drug response including toxicity. The genome sequencing projects are bringing ...

    SBIRPhase I2002Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government